{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:59:56Z","timestamp":1793606396341,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005851","name":"shahid beheshti university of medical sciences","doi-asserted-by":"publisher","award":["15729"],"award-info":[{"award-number":["15729"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Shigellosis is a self-limiting disease that antibiotic therapy could decrease its complications and duration. However, sublethal levels of antibiotics, may lead to alteration in disease state, besides its role in the emergence of resistant variants. To understand this link, we investigated diversity of\n                      <jats:italic>Shigella<\/jats:italic>\n                      serogroups in children with diarrhea, diversity of\n                      <jats:italic>S. flexneri<\/jats:italic>\n                      serotypes, cytotoxic potential, resistance patterns to antibiotics, and alteration in transcriptional expression of main virulence genes in response to sub-inhibitory concentrations of azithromycin and ciprofloxacin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The most frequently isolated serogroups were\n                      <jats:italic>S. sonnei<\/jats:italic>\n                      (70.3%), followed by\n                      <jats:italic>S. flexneri<\/jats:italic>\n                      (29.1%) and\n                      <jats:italic>S. boydii<\/jats:italic>\n                      (0.6%). Ten serotypes were characterized among the\n                      <jats:italic>S. flexneri<\/jats:italic>\n                      isolates, including 2b, 1b, 2a, 1c, 4a, 3a, 3b, 6 and X and\/or Xv. Antimicrobial susceptibility testing showed low frequency of multi-drug resistance phenotype among\n                      <jats:italic>S. flexneri<\/jats:italic>\n                      isolates with minimum inhibitory concentrations (MIC) of 0.5\u201364 and 0.25\u20138\u00a0\u00b5g\/mL for azithromycin and ciprofloxacin, respectively. Gene expression analysis showed upregulation of\n                      <jats:italic>icsA<\/jats:italic>\n                      in serotype 4a after exposure with azithromycin, whereas other genes in the VirF pathway were downregulated, and downregulation of\n                      <jats:italic>virB<\/jats:italic>\n                      in serotypes 2a and 3a after exposure with ciprofloxacin, while upregulation of noted genes was detected.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Alteration in transcription of key virulence genes of\n                      <jats:italic>S. flexneri<\/jats:italic>\n                      serotypes was shown in response to sublethal concentration of antibiotics. The detected incongruency in the extent of gene transcription proposed that diverse regulatory pathways are possibly mediating response to sub-MIC concentrations of antibiotics in\n                      <jats:italic>S. flexneri<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13099-022-00483-3","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T13:03:02Z","timestamp":1645534982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Virulence genes expression profiling of different Shigella flexneri serotypes in response to sub-inhibitory concentrations of azithromycin and ciprofloxacin"],"prefix":"10.1186","volume":"14","author":[{"given":"Mehrzad","family":"Sadredinamin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdollah","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Sohrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadmahdi","family":"Karimi-Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1998-2716","authenticated-orcid":false,"given":"Zohreh","family":"Ghalavand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Alebouyeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"key":"483_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0140-6736(17)33296-8","volume":"391","author":"KL Kotloff","year":"2018","unstructured":"Kotloff KL, Riddle MS, Platts-Mills JA, Pavlinac P, Zaidi AK. Shigellosis. Lancet. 2018;391:801\u201312.","journal-title":"Lancet"},{"key":"483_CR2","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1128\/JCM.41.11.5053-5058.2003","volume":"41","author":"KA Talukder","year":"2003","unstructured":"Talukder KA, Islam MA, Khajanchi BK, Dutta DK, Islam Z, Safa A, et al. Temporal shifts in the dominance of serotypes of Shigella dysenteriae from 1999 to 2002 in Dhaka Bangladesh. J Clin Microbiol. 2003;41:5053\u20138.","journal-title":"J Clin Microbiol"},{"key":"483_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1128\/JCM.01592-18","volume":"57","author":"SP Brengi","year":"2019","unstructured":"Brengi SP, Sun Q, Bola\u00f1os H, Duarte F, Jenkins C, Pichel M, et al. PCR-based method for Shigella flexneri serotyping: international multicenter validation. J Clin Microbiol. 2019;57:4.","journal-title":"J Clin Microbiol"},{"key":"483_CR4","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1128\/JCM.01259-11","volume":"49","author":"Q Sun","year":"2011","unstructured":"Sun Q, Lan R, Wang Y, Zhao A, Zhang S, Wang J, et al. Development of a multiplex PCR assay targeting O-antigen modification genes for molecular serotyping of Shigella flexneri. J Clin Microbiol. 2011;49:3766\u201370.","journal-title":"J Clin Microbiol"},{"key":"483_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01592-18","author":"SP Brengi","year":"2019","unstructured":"Brengi SP, Sun Q, Bola\u00f1os H, Duarte F, Jenkins C, Pichel M, et al. PCR-based method for Shigella flexneri serotyping: international multicenter validation. J Clin Microbiol. 2019. https:\/\/doi.org\/10.1128\/JCM.01592-18.","journal-title":"J Clin Microbiol"},{"key":"483_CR6","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1128\/JCM.03386-15","volume":"54","author":"A Gentle","year":"2016","unstructured":"Gentle A, Ashton PM, Dallman TJ, Jenkins C. Evaluation of Molecular methods for serotyping Shigella flexneri. J Clin Microbiol. 2016;54:1456\u201361.","journal-title":"J Clin Microbiol"},{"key":"483_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nrgastro.2013.12","volume":"10","author":"EM Barry","year":"2013","unstructured":"Barry EM, Pasetti MF, Sztein MB, Fasano A, Kotloff KL, Levine MM. Progress and pitfalls in Shigella vaccine research. Nat Rev Gastroenterol Hepatol. 2013;10:245.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"483_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1128\/CMR.00032-07","volume":"21","author":"GN Schroeder","year":"2008","unstructured":"Schroeder GN, Hilbi H. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev. 2008;21:134\u201356.","journal-title":"Clin Microbiol Rev"},{"key":"483_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fcimb.2017.00064","volume":"7","author":"E Mattock","year":"2017","unstructured":"Mattock E, Blocker AJ. How do the virulence factors of Shigella work together to cause disease? Front Cell Infect Microbiol. 2017;7:64.","journal-title":"Front Cell Infect Microbiol"},{"key":"483_CR10","unstructured":"World Organization Health. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. 2005."},{"key":"483_CR11","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1080\/20469047.2017.1409454","volume":"38","author":"PC Williams","year":"2018","unstructured":"Williams PC, Berkley JA. Guidelines for the treatment of dysentery (shigellosis): a systematic review of the evidence. Paediatr Int Child Health. 2018;38:S50\u201365.","journal-title":"Paediatr Int Child Health"},{"issue":"4","key":"483_CR12","doi-asserted-by":"publisher","first-page":"e01748","DOI":"10.1128\/AAC.01748-17","volume":"62","author":"TC Darton","year":"2018","unstructured":"Darton TC, Tuyen HT, Newton PN, Dance DA, Phetsouvanh R, Davong V, et al. Azithromycin resistance in Shigella spp.Southeast Asia. Antimicrob Agents Chemother. 2018;62(4):e01748-e1817.","journal-title":"Antimicrob Agents Chemother"},{"key":"483_CR13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2147\/IDR.S238559","volume":"13","author":"M Karimi-Yazdi","year":"2020","unstructured":"Karimi-Yazdi M, Ghalavand Z, Shabani M, Houri H, Sadredinamin M, Taheri M, et al. High rates of antimicrobial resistance and virulence gene distribution among Shigella spp. isolated from pediatric patients in Tehran Iran. Infect Drug Resist. 2020;13:485.","journal-title":"Infect Drug Resist"},{"key":"483_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.20411\/pai.v2i1.174","volume":"2","author":"RJ Gruninger","year":"2017","unstructured":"Gruninger RJ, Johnson RA, Das SK, Nelson EJ, Spivak ES, Contreras JR, et al. Socioeconomic determinants of ciprofloxacin-resistant Shigella infections in Bangladeshi children. Pathog Immun. 2017;2:89.","journal-title":"Pathog Immun"},{"key":"483_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrmicro3270","volume":"12","author":"DI Andersson","year":"2014","unstructured":"Andersson DI, Hughes D. Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol. 2014;12:465\u201378.","journal-title":"Nat Rev Microbiol"},{"key":"483_CR16","first-page":"2241","volume":"10","author":"WB Chi","year":"2020","unstructured":"Chi WB, Zoqratt MZHM, Gan I, Ayub Q, Siew TH. A fluoroquinolone-sensitive Shigella sonnei UKMCC1015 downregulates the expression of ribosomal proteins in response to sub-lethal concentration of norfloxacin. BioRxiv. 2020;10:2241.","journal-title":"BioRxiv"},{"key":"483_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40794-019-0079-7","volume":"5","author":"A Alemu","year":"2019","unstructured":"Alemu A, Geta M, Taye S, Eshetie S, Engda T. Prevalence, associated risk factors and antimicrobial susceptibility patterns of Shigella infections among diarrheic pediatric population attending at Gondar town healthcare institutions, Northwest Ethiopia. Trop Dis Travel Med Vaccines. 2019;5:7.","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"483_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/1471-2334-9-204","volume":"9","author":"H Vinh","year":"2009","unstructured":"Vinh H, Nhu NTK, Nga TVT, Duy PT, Campbell JI, Hoang NVM, et al. A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infect Dis. 2009;9:204.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"483_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1089\/fpd.2008.0109","volume":"2008","author":"A Bangtrakulnonth","year":"2008","unstructured":"Bangtrakulnonth A, Vieira AR, Lo Fo Wong DM, Pornreongwong S, Pulsrikarn C, Sawanpanyalert P, et al. Shigella from humans in Thailand during 1993 to 2006: spatial-time trends in species and serotype distribution. Foodborne Pathog Dis. 2008;2008(5):773\u201384.","journal-title":"Foodborne Pathog Dis"},{"key":"483_CR20","first-page":"225","volume":"6","author":"S Khaghani","year":"2014","unstructured":"Khaghani S, Shamsizadeh A, Nikfar R, Hesami A. Shigella flexneri: a three-year antimicrobial resistance monitoring of isolates in a Children Hospital, Ahvaz Iran. Iran J Microbiol. 2014;6:225.","journal-title":"Iran J Microbiol"},{"key":"483_CR21","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1097\/INF.0000000000002791","volume":"39","author":"I Nisa","year":"2020","unstructured":"Nisa I, Haroon M, Qasim M, Driessen A, Nijland J, Yasin N, et al. Association of serotype with antimicrobial resistance patterns among Shigella flexneri isolates from Pakistan: the importance of serotype 2b. Pediatr Infect Dis J. 2020;39:e352\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"483_CR22","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1128\/JCM.39.10.3757-3759.2001","volume":"39","author":"KA Talukder","year":"2001","unstructured":"Talukder KA, Dutta DK, Safa A, Ansaruzzaman M, Hassan F, Alam K, et al. Altering trends in the dominance of Shigella flexneri serotypes and emergence of serologically Atypical S. flexneri strains in Dhaka Bangladesh. J Clin Microbiol. 2001;39:3757\u20139.","journal-title":"J Clin Microbiol"},{"key":"483_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13099-019-0314-9","volume":"11","author":"A Das","year":"2019","unstructured":"Das A, Mandal J. Extensive inter-strain diversity among clinical isolates of Shigella flexneri with reference to its serotype, virulence traits and plasmid incompatibility types, a study from south India over a 6-year period. Gut Pathogens. 2019;11:33.","journal-title":"Gut Pathogens"},{"key":"483_CR24","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3855\/jidc.3692","volume":"8","author":"M Qu","year":"2014","unstructured":"Qu M, Zhang X, Liu G, Huang Y, Jia L, Liang W, et al. An eight-year study of Shigella species in Beijing, China: serodiversity, virulence genes, and antimicrobial resistance. J Infect Dev Ctries. 2014;8:904\u20138.","journal-title":"J Infect Dev Ctries"},{"key":"483_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12866-019-1495-6","volume":"19","author":"Y Wang","year":"2019","unstructured":"Wang Y, Ma Q, Hao R, Zhang Q, Yao S, Han J, et al. Antimicrobial resistance and genetic characterization of Shigella spp. in Shanxi Province, China, during 2006\u20132016. BMC Microbiol. 2019;19:116.","journal-title":"BMC Microbiol"},{"key":"483_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1017\/S095026880300147X","volume":"132","author":"V Vasilev","year":"2004","unstructured":"Vasilev V, Andorn N, Japheth R, Agmon V. Variability of Shigella flexneri serotypes in Israel during a period of two years: 2000 and 2001. Epidemiol Infect. 2004;132:51\u20136.","journal-title":"Epidemiol Infect"},{"key":"483_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2147\/IDR.S194740","volume":"12","author":"M Moosavian","year":"2019","unstructured":"Moosavian M, Ghaderiyan GH, Shahin M, Navidifar T. First investigation of the presence of SPATE genes in Shigella species isolated from children with diarrhea infection in Ahvaz, southwest Iran. Infection and Drug Resistance. 2019;12:795.","journal-title":"Infection and Drug Resistance"},{"key":"483_CR28","doi-asserted-by":"publisher","first-page":"e01422","DOI":"10.1128\/JCM.01422-18","volume":"57","author":"M Salah","year":"2019","unstructured":"Salah M, Shtayeh I, Ghneim R, Al-Qass R, Sabateen A, Marzouqa H, et al. Evaluation of Shigella species azithromycin CLSI epidemiological cutoff values and macrolide resistance genes. J Clin Microbiol. 2019;57:e01422-e1518.","journal-title":"J Clin Microbiol"},{"key":"483_CR29","volume-title":"Dysentery (Shigellosis) current WHO guidelines and the WHO essential\u201d medicine list for children","author":"P Williams","year":"2016","unstructured":"Williams P, Berkley J. Dysentery (Shigellosis) current WHO guidelines and the WHO essential\u201d medicine list for children. Geneva: World Health Organization; 2016."},{"key":"483_CR30","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1089\/mdr.2018.0229","volume":"25","author":"H Kang","year":"2019","unstructured":"Kang H, Wang L, Li Y, Lu Y, Fan W, Bi R, et al. Dissemination of multidrug-resistant Shigella flexneri and Shigella sonnei with class 1, class 2, and atypical class 1 integrons in China. Microb Drug Resist. 2019;25:1465\u201374.","journal-title":"Microb Drug Resist"},{"key":"483_CR31","doi-asserted-by":"publisher","first-page":"e82601","DOI":"10.1371\/journal.pone.0082601","volume":"8","author":"AI Ud-Din","year":"2013","unstructured":"Ud-Din AI, Wahid SU, Latif HA, Shahnaij M, Akter M, Azmi IJ, et al. Changing trends in the prevalence of Shigella species: emergence of multi-drug resistant Shigella sonnei biotype g in Bangladesh. PLoS ONE. 2013;8:e82601.","journal-title":"PLoS ONE"},{"key":"483_CR32","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1128\/JCM.01790-16","volume":"55","author":"MA Chattaway","year":"2017","unstructured":"Chattaway MA, Schaefer U, Tewolde R, Dallman TJ, Jenkins C. Identification of Escherichia coli and Shigella species from whole-genome sequences. J Clin Microbiol. 2017;55:616\u201323.","journal-title":"J Clin Microbiol"},{"key":"483_CR33","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1128\/AAC.06315-11","volume":"56","author":"M Bielaszewska","year":"2012","unstructured":"Bielaszewska M, Idelevich EA, Zhang W, Bauwens A, Schaumburg F, Mellmann A, et al. Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimicrob Agents Chemother. 2012;56:3277\u201382.","journal-title":"Antimicrob Agents Chemother"},{"key":"483_CR34","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.3389\/fmicb.2017.02689","volume":"8","author":"Z Lin","year":"2018","unstructured":"Lin Z, Cai X, Chen M, Ye L, Wu Y, Wang X, et al. Virulence and stress responses of Shigella flexneri regulated by PhoP\/PhoQ. Front Microbiol. 2018;8:2689.","journal-title":"Front Microbiol"},{"key":"483_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1089\/fpd.2007.0062","volume":"5","author":"SE Dowd","year":"2008","unstructured":"Dowd SE, Killinger-Mann K, Brashears M, Fralick J. Evaluation of gene expression in a single antibiotic exposure-derived isolate of Salmonella enterica typhimurium 14028 possessing resistance to multiple antibiotics. Foodborne Pathog Dis. 2008;5:205\u201321.","journal-title":"Foodborne Pathog Dis"},{"key":"483_CR36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2958.2006.05376.x","volume":"62","author":"AK Sharma","year":"2006","unstructured":"Sharma AK, Payne SM. Induction of expression of hfq by DksA is essential for Shigella flexneri virulence. Mol Microbiol. 2006;62:469\u201379.","journal-title":"Mol Microbiol"},{"key":"483_CR37","unstructured":"Sharma AK. Role of DksA and Hfq in Shigella flexneri virulence. 2007."},{"key":"483_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2407-6-33","volume":"6","author":"N Hu","year":"2006","unstructured":"Hu N, Qian L, Hu Y, Shou J-Z, Wang C, Giffen C, et al. Quantitative real-time RT-PCR validation of differential mRNA expression of SPARC, FADD, Fascin, COL7A1, CK4, TGM3, ECM1, PPL and EVPLin esophageal squamous cell carcinoma. BMC Cancer. 2006;6:33.","journal-title":"BMC Cancer"},{"key":"483_CR39","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1128\/IAI.00919-13","volume":"81","author":"V Koppolu","year":"2013","unstructured":"Koppolu V, Osaka I, Skredenske JM, Kettle B, Hefty PS, Li J, et al. Small-molecule inhibitor of the Shigella flexneri master virulence regulator VirF. Infect Immun. 2013;81:4220\u201331.","journal-title":"Infect Immun"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-022-00483-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-022-00483-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-022-00483-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T13:03:48Z","timestamp":1645535028000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-022-00483-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1186\/s13099-022-00483-3","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"17 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}